SCHEMBL8979205

SCHEMBL8979205

CNN(C)c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
TDP1 Q9NUW8 2/20 0.42
POLB P06746 1/20 0.42
HPGD P15428 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX15 P16050 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.40
CYP2A6 P11509 1/20 0.40
CNR2 P34972 1/20 0.39
TSHR P16473 1/20 0.38
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
TAAR1 Q96RJ0 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA3 P07451 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6835309 0.79 ALDH1A1 (0.61) ALDH1A1TDP1HPGDKDM4EALOX15
SCHEMBL6567263 0.77 ALDH1A1 (0.55) ALDH1A1TDP1HPGDKDM4EALOX15
SCHEMBL19182388 0.75 APP (0.45) ALDH1A1KDM4EALOX15HSD17B10LMNA
SCHEMBL677668 0.74 LMNA (0.46) ALDH1A1LMNATSHRCA12CA1
SCHEMBL8979210 0.73 HTR3E (0.50) TDP1LMNATSHRTAAR1SLC6A2
SCHEMBL11001802 0.73 ALDH1A1 (0.42) ALDH1A1TDP1POLBHPGDKDM4E
SCHEMBL5213200 0.73 CHKA (0.55) ALDH1A1TDP1POLBHPGDKDM4E
SCHEMBL59751 0.73 ALDH1A1 (0.69) ALDH1A1TDP1POLBHPGDKDM4E
SCHEMBL31116653 0.73 ALDH1A1 (0.69) ALDH1A1TDP1POLBHPGDKDM4E
Hydrochloric Acid SCHEMBL4552761 0.72 LMNA (0.45) ALDH1A1TDP1KDM4ELMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188097-B2 Pyrazolo[1,5-A]pyrimidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
US-8188097-B2 Pyrazolo[1,5-A]pyrimidine compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-05-29 US disclosed
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds TANABE SEIYAKU CO., LTD. (JP) 2009-03-12 US disclosed
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds TANABE SEIYAKU CO., LTD. (JP) 2009-03-12 US disclosed
WO-2007046548-A1 PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CANNABINOID RECEPTOR ANTAGONISTS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069298-A1 Pyrazolo[1,5-A]Pyrimidine Compounds RECQL, QTRT1, DPYD ALDH1A1 467/4885TDP1 1059/4885POLB 1269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.